Corrective & Preventive Action (CAPA)
The CAPA (Corrective and Preventive Action) process is a critical GMP requirement under RDC 752/2022. It is the primary mechanism for addressing non-conformities and preventing their recurrence.
Corrective action addresses an existing non-conformity or adverse event — identifying root cause and eliminating it.
Preventive action addresses potential non-conformities before they occur — identifying potential causes and eliminating them.
The CAPA process must include:
- Identification of the problem or potential problem;
- Root cause analysis;
- Definition of corrective/preventive measures;
- Implementation of measures;
- Verification that measures were effective; and
- Communication to management.
All CAPAs must be documented in the quality system and available to ANVISA inspectors. ANVISA inspection findings that result in non-conformity notices must be addressed through the CAPA process.
Verify all information against official ANVISA sources before making regulatory decisions.